inner-banner-bg

Journal of Clinical & Experimental Immunology(JCEI)

ISSN: 2475-6296 | DOI: 10.33140/JCEI

Impact Factor: 1.9

Pre-Solid-Organ-Transplant COVID-19 Vaccination

Abstract

Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn and Porntep Siriwanarangsun

Vaccine such as influenza vaccine, is administered in stable transplant recipients, although live attenuated virus vaccines are contraindicated, generally due to risk of disseminated infection [1, 2]. Neither efficacy, safety, nor durability are well known in transplant recipients due to exclusion of them from recent COVID-19 vaccine trials [1, 2].

PDF